Category- Allopathy
Medicine Highlights
| Uses | 1. To manage type 2 Diabetes mellitus. |
| Common Side Effects | 1. Headache 2. Cough 3. Constipation 4. Excessive sweating 5. Weakness 6. Unusual muscle pain 7. Feeling cold 8. Trouble breathing 9. Feeling dizzy, light-headed, tired, or very weak 10. Stomach pain, vomiting 11. Slow or irregular heart rate. |
| Additional Information | 1. Take this medication 15 to 30 minutes before meals to get a good effect. |
| Storage | 1. The medicine should be stored at room temperature. 2. Keep away from sunlight and moisture. 3. Keep away from the reach of children |
| How to Take This Medicine | Take this medicine orally with a sip of water. |
BrandName Uses
BrandName is an oral medicine belonging to the category of antidiabetic drugs and is used for the treatment of type 2 diabetes mellitus.
BrandName side effects
More Common
- Headache
- Cough
- Constipation
- Excessive sweating
- Weakness
- Unusual muscle pain
- Feeling cold
- Trouble breathing
- Feeling dizzy, light-headed, tired, or very weak
- Stomach pain, vomiting
- Slow or irregular heart rate.
Less Common
- Swelling of the face, lips, or eyelids
- Heartburn
- Liver enzyme elevation
- Low blood sugar
- Nausea, upset stomach
- Diarrhea
How BrandName works
In type 2 diabetes, the body either doesn’t produce enough insulin or doesn’t respond to it properly, leading to high blood sugar levels. Dapagliflozin works mainly in the liver: it reduces how much glucose the liver produces and helps muscles use insulin more effectively. Teneligliptin belongs to a group called DPP-4 inhibitors. It stops the breakdown of hormones like GLP-1 and GIP, which signal the pancreas to release insulin after meals and reduce glucagon, the hormone that raises blood sugar. When taken together, these medicines help your body manage blood sugar more naturally, especially after eating, with fewer chances of sudden sugar drops.
Safety Measures and Warning
Pregnancy
Due to a lack of studies on the effects of BrandName on the fetus during pregnancy, its safety is not clearly established. Therefore, if you are pregnant or planning to conceive, inform your doctor.
Breastfeeding
BrandName pass into breast milk. Tell your doctor if you are breastfeeding or plan to breastfeed, and they will advise if you should stop breastfeeding or stop BrandName.
Kidney and Liver Problems
Patients suffering from kidney and liver problems are more prone to kidney and liver damage, as the drug is made into a less toxic form in the liver and kidney, so consult a doctor before using it.
BrandName Interaction with Food Product
Alcohol and smoking can simultaneously affect the drug’s action and show an effect on blood glucose levels by affecting the liver and pancreas. It can sometimes increase blood sugar levels and sometimes decrease blood sugar levels.
BrandName Interaction with Other Medicines
Avoid taking the BrandName combination with the following medicines, as it may increase or decrease the desired effect, or in worse cases, it could be fatal:
BrandName Chemical Structure
IUPAC (International Union of Pure and Applied Chemistry)/ Chemical name
Teneligliptin- [(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl) -1-piperazinyl]-2-pyrrolidinyl] (1,3-thiazolidin-3-yl) methanone

Dapagliflozin- (2S,3R,4R,5S,6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol.

Intake routine/cycle
Daily dose
Take BrandName exactly as your doctor recommends. The dose may change based on your condition and how well you respond. Do not take more than prescribed without consulting your doctor.
Missed Dose
If you forget to take your medicine, take the medication as soon as you remember. If it’s nearly time for your next dose, skip the missed one and continue with your regular schedule. Always consult the doctor before making any changes to your dosage.
Overdose
It is not recommended to take more than 400 mg of teneligliptin and 250 mg of dapagliflozin per day, as it may cause severe overdosing effects like extreme dizziness, confusion, low blood pressure, liver damage, low blood sugar levels, swelling, muscle damage, and seizures. Immediately give the patient fruit or glucose-containing liquids and sugary foods to minimize the effects. If you face any of the severe effects, take him to the doctor.
Storage
- Store the medicine at room temperature
- Keep away from sunlight and moisture
- Keep out of reach of children
Directions for use
- Take BrandName exactly as prescribed by your doctor, at the same time each day.
- Do not stop taking BrandName without your doctor’s approval, even if you feel better.
- If you forget to take BrandName, take them as soon as you remember. If it’s almost time for your next dose, skip the missed dose.
BrandName Summary
The BrandName combination is a medicine used to manage type 2 diabetes when diet and exercise alone aren’t enough. It works in two ways: teneligliptin helps the body release more insulin and reduce excess sugar made by the liver, while dapagliflozin lowers sugar production and improves how the body uses insulin. Together, they help control blood sugar levels without causing too many lows. Common side effects include stomach upset, headache, dizziness, and tiredness usually mild and manageable. It’s not suitable for people with serious kidney, liver, or heart problems, or during pregnancy. Alcohol should be avoided while taking it, as it can increase the risk of serious complications like lactic acidosis. To reduce stomach issues, it’s best taken with meals.
FAQ’s
What is the teneligliptin dose with dapagliflozin?
Teneligliptin and dapagliflozin are one of the most effective combinations for the treatment of type 2 diabetes, and the commonly used dose of teneligliptin is 20 mg in different combinations of dapagliflozin.
What are the uses of BrandName tablets?
BrandName are a combination medicine used to manage type 2 diabetes when diet and exercise alone aren’t enough. It works in two ways: teneligliptin helps the body release more insulin and reduce excess sugar made by the liver, while dapagliflozin lowers sugar production and improves how the body uses insulin
What is BrandName mode of action?
In type 2 diabetes, the body either doesn’t produce enough insulin or doesn’t respond to it properly, leading to high blood sugar levels. Dapagliflozin works mainly in the liver: it reduces how much glucose the liver produces and helps muscles use insulin effectively. Teneligliptin belongs to a group called DPP-4 inhibitors. It stops the breakdown of hormones like GLP-1 and GIP, which signal the pancreas to release insulin after meals and reduce glucagon, the hormone that raises blood sugar. When taken together, these medicines help your body manage blood sugar more naturally, especially after eating, with fewer chances of sudden sugar drops.
Reference
- Practo. Dapagliflozin [Internet]. [cited 2025 Sep 30]. Available from.
- Mayo Clinic. Dapagliflozin (oral route) [Internet]. [cited 2025 Sep 30]. Available from.
- Drugs.com. Dapagliflozin [Internet]. [cited 2025 Sep 30]. Available from.\
- National Center for Biotechnology Information. PubChem Compound Summary for CID 1152270, Dapagliflozin [Internet]. Bethesda (MD): National Library of Medicine; [cited 2025 Sep 30]. Available from.
- ScienceDirect. Teneligliptin [Internet]. Amsterdam: Elsevier; [cited 2025 Sep 29]. Available from.
- Medical Dialogues. Teneligliptin [Internet]. New Delhi: Medical Dialogues; [cited 2025 Sep 29]. Available from.
- Practo. Teneligliptin [Internet]. Bengaluru: Practo Technologies Pvt Ltd; [cited 2025 Sep 29]. Available from.
- Kishimoto M. Teneligliptin: a novel DPP-4 inhibitor for the treatment of type 2 diabetes. Drug Des Devel Ther [Internet]. 2016 [cited 2025 Sep 29];10:1591–6. Available from.

Siva Krishna Adithya Bhumireddy completed Bachelor of Pharmacy from GIET School of Pharmacy affiliated to Andhra University and from his 3rd year of graduation itself he was working as a freelance Medical and Publication writer and having expertise in Systematic reviews and clinical research. With his keen interest and skills in research and documentation practices he also reviewed more than 100 manuscripts from international journals like Elsevier, Springer Nature, Sage Journals and all the manuscripts were indexed and appeared in Pub Med, Scopus and Web of Science databases and received honorary recognition letters and certificates from all of them. Siva Krishna Adithya also published few systematic, narrative reviews and few chapters of international expertise.